EUVIMEDEUVIMED entdecken
Open Access

Clostridioides difficile Infection in Aged Mice Decreases Memory Function, Which Can Be Protected with Alanyl-Glutamine Supplementation

Sophia M Goldbeck, Deiziane Vs Costa, Suemin E Yang, Caroline C Whitt, Ayesha E Tora, Cirle A Warren, Jae Hyun Shin

The Journal of Nutrition · 2025

DOI: 10.1016/j.tjnut.2025.03.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Nutrition, 2025. Verfasst von Sophia M Goldbeck und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina School of Medicine, Chapel Hill, NC, United States; Division of Infectious Diseases and International Health, University…. Hauptthemen laut MEDLINE: Dipeptides, Clostridium Infections, Dietary Supplements, Clostridioides difficile. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adults aged >65 face a higher risk of both Clostridioides difficile infection (CDI) and dementia. CDI in the elderly may exacerbate functional and cognitive impairments. Current CDI treatment options are limited. Alanyl-glutamine (AQ) is a dipeptide shown to decrease C. difficile toxin effects in vitro and in vivo. OBJECTIVES: We tested the potential benefits of AQ on the clinical outcomes and cognitive impairment in the aged mouse model of CDI treated at various timings of AQ and vancomycin treatment. METHODS: C57BL/6 retired breeder (9 mo) and aged (18 mo) mice were treated with AQ-supplemented water as a 2-wk pretreatment or continuously. The mice underwent a standard CDI protocol (VPI10463) and were treated, or not, with vancomycin. Disease severity was tracked for 14 d, then novel object recognition (NOR) tests for acute memory were performed. Hippocampal tissues were assayed for molecular markers. RESULTS: NOR testing confirmed CDI-induced cognitive impairment (P = 0.0352). AQ pretreatment had mild neuroprotective effects during CDI. Mice treated with vancomycin and continuous AQ had better clinical scores and better memory performance than vancomycin controls (P = 0.0286). Continuous AQ treatment, when used alone or paired with vancomycin, offered protection against CDI-induced cognitive impairment. The mechanism of CDI-induced memory impairment remains unclear, but infected mice had elevated synaptobrevin-2 (P = 0.0396) and neural cell adhesion molecule (P = 0.008) compared with uninfected controls on day 14 post infection. CONCLUSIONS: Our findings suggest that neuroinflammation and memory loss occur during CDI, which may be ameliorated by AQ supplementation. AQ supplementation may have both neurological and intestinal protective effects during CDI treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesClostridium InfectionsDietary SupplementsClostridioides difficileMemoryAgingMemory DisordersAnimalsMice, Inbred C57BLMiceVancomycinMaleAnti-Bacterial AgentsHippocampusDisease Models, Animal

Stichwörter der Autor:innen

Alanyl-glutamineClostridioides difficilecognitiondementiagut–brain axis

Substanzen

DipeptidesalanylglutamineVancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • University of North Carolina School of Medicine, Chapel Hill, NC, United States; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States.
  • Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States.
  • Department of Physical and Rehabilitation Medicine, University of Virginia, Charlottesville, VA, United States; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, United States.
  • Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States. Electronic address: ca6t@virginia.edu.
  • Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States; Hoag Memorial Hospital Presbyterian, Newport Beach, CA, United States.

Förderung

  • NIA NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Zitieren

APA

Goldbeck, S. M., Costa, D. V., Yang, S. E., Whitt, C. C., Tora, A. E., Warren, C. A., & Shin, J. H. (2025). Clostridioides difficile Infection in Aged Mice Decreases Memory Function, Which Can Be Protected with Alanyl-Glutamine Supplementation. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2025.03.032

Vancouver

Goldbeck SM, Costa DV, Yang SE, Whitt CC, Tora AE, Warren CA, et al. Clostridioides difficile Infection in Aged Mice Decreases Memory Function, Which Can Be Protected with Alanyl-Glutamine Supplementation. The Journal of Nutrition. 2025. doi:10.1016/j.tjnut.2025.03.032

BibTeX
@article{Goldbeck2025,
  author = {Goldbeck, Sophia M and Costa, Deiziane Vs and Yang, Suemin E and Whitt, Caroline C and Tora, Ayesha E and Warren, Cirle A and Shin, Jae Hyun},
  title = {Clostridioides difficile Infection in Aged Mice Decreases Memory Function, Which Can Be Protected with Alanyl-Glutamine Supplementation},
  journal = {The Journal of Nutrition},
  year = {2025},
  doi = {10.1016/j.tjnut.2025.03.032}
}
Kostenlos starten →